You are here

Home » Content

ORAL KANDİDİAZİS (OLGU BİLDİRİMİ)

ORAL CANDIDIASIS (CASE REPORT)

Journal Name:

  • Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 1998

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Candidiais in an important disease affecting the oral cavity in a significant percentage of the population. Jt is now widely accepted that as much as 60 % of healthy adults may harbor commensal candidal microorganisms without demonstrating any clinical signs or symptoms of mucosal disease. Oral candidiasis may serve as a useful clinical marker for the presence of significant predisposing conditions. In our case there was no finding of any systemic diseases. In our Candida microbiological analyse, C.parapsilosis. C.kmsei, have reproduced in different times. Our aim to present this case is that it fias showed resistance to all antimicotics those had been given and it has recovered by a preparation including flucytosine.
Bookmark/Search this post with
Abstract (Original Language): 
Kandidiazis toplumun büyük bir bölümünün oral kavitcstni etkileyen önemli bir hastalıklın Bugün, sağlıklı yetişkinlerin yaklaşık % 60'ında kommcnsal kandidal mikroorganizmaların klinik olarak herhangi bir mukozal hastalık belirtisi veya semptomu göstermeden bulunduğu kabul edilmektedir. Oral kandidiazi s belirli predispoze durumların varlığı için yararlı bir marker olarak kullanılabilir. Bizim vakamızda hiçbir sistemik hastalık bulgusu yoklu. Yaptığımız mikrobiyolojik incelemelerde değişik zamanlarda C.parapsılosİs, C.kruseı üredL Olgumuzu sunmaktaki amacımız verilen bütün antimikotik ilaçlara direnç göstermesi ve flucytosine içeren bir preparatia iyileşmesidir.
FULL TEXT (PDF): 
PDF icon arastirmax-oral-kandidiazis-olgu-bildirimi.pdf
  • 1
50-53
  • Turkish

REFERENCES

References: 

1.
An
ğ O. Ağız Mikrobiyolojisi- İkinci baskı, İstanbul: İstanbul Üniversitesi, 1981.
2. Arendorf TM, Walker DM, Oral candidal populations in health arid disease. Br Dent J 1979; 147: 267-72.
3. Berdicevsky I, Ben-Aryeh H, Szargel R, Gutman D. Oral Candida in children. Oral Surg Oral Med Oral Pathol 1984; 57; 37-40.
4. Challocombe SJ- Immunology of oral candidiasis. In; Samaranayakc LP, MaeFarJane TW. eds. Oral candidiasis. Umdon: Wright. 1990: 104-23.
5. Challocombe SJ. Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 1994; 78: 202-10.
6. Cirelli Av Rossi F, Ciardi M. Treatment of oropharyngeal and esophageal candidiasis with a new antifungal agent, fluconazole, in HIV-infecLed patients, therapeutic Research 1990; 47: 81-7.
7. Dupont B, Durouhet P.. Hueonazole in the management or oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. Journal of Medical and Veterinary Mycology 198S; 26: 67-71.
8. Fotos PG, Vincent SD, Hellstein JW. Oral candidosis; Clinical, historical and therapeutic features of 100 cases. Oral Surg Oral Mud Oral Pathol 1992; 74; 41-9.
9. Holmstrup P, Dabclnleen E. The frequency of Candida in oral lichen planus. Scand J Dent Res 1974; 82; 5S4-7.
10. Jones JH, Mason DK. Oral manifestations of systemic disease. Sec rid. London; Baillicre Tindall 1990: 561-6.
11. Krogh P, Holmstrup P, Thorh J J, Vedtoftc P, Pindborg JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987;63:48-54.
12. Lynch MA, Brightman VJ, Greenberg M. Burkcfs Oral Medicine, Diagnosis and Treatment. 9ed Philadelphia: JB Lippincott Com, 1994; 257-66.
13. Lynch DP. Oral Candidiasis, History, classification and clinical presentation. Oral Surg Oral Med Oral Pathol 1994; 78; L89-93-
52
Atatürk Üniv.Diş HekhakDerg, Cilt:8, Sayirl, Sayfa:50 53,1998
AK.ÜNÜR.GUÇ
14. Martin MV, Lamb DJ. Frequency of Candida albicans serotypes in patients with denture-induced stomatitis and in normal denture wearers. J Clin Pathol 19R2; 35: 881-91.
15. McCuilought MJ, Ross BC, Reade PC. Candida albicans; it review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation. Int J Oral Maxillofac Surg 1996; 25: 136-44.
16. Navazesh M, Wood GJ, Brightman VJ. Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 284-8.
17. Oppenheim FG, Xu T, McMilljan FM et al. Histatins, a novel family of histatine-rich proteins in human parotid secretion; isolation, characterization, primary structure and fungistatic effects on Candida alhicans. J Biol Chem 1988;263:7472-7.
18. Regezi JA. Sciubba J. Oral Pathology. Sec ed. Philadelphia: WB Saunders Com 1993; 114-20.
19. Bobbins SL, Kumar V, Basic Pathology. Fourth ed. Philadelphia: WB Saunders Com 1987.
20. Sofi DR. High-frequency switching in Candida albicans and its relations to vaginal candidosis. Am J Obstet Cynccol 1988; 15S: 997 1001.
21. Soli DR, Morrow B, Srikantha T, Vargas K, Wert/ P. Developmental and molckular biology of switching in Candida albicans. Oral Surg Oral Med Oral Pathol 1994; 78: 194-201.
22.
Topç
u AW, Söyletir G, Doğanay M. İnfeksiyon Hastalıkları.. In: Tümbay H, İnci R, ed. Antifungal ilaçlar. İstanbul: Nobel Tıp Kitabetleri. 1996: 195-203.

Thank you for copying data from http://www.arastirmax.com